Top compounds associated with response to RP11-240B13.2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.09
mRNA purmorphamine CTRPv2 pan-cancer AAC 0.062 0.1
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.055 0.1
mRNA YL54 CTRPv2 pan-cancer AAC 0.063 0.1
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.052 0.1
mRNA fingolimod CTRPv2 pan-cancer AAC 0.056 0.1
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.1
mRNA ETP-46464 CTRPv2 pan-cancer AAC -0.066 0.1
mRNA itraconazole CTRPv2 pan-cancer AAC 0.058 0.1
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.058 0.1
Download CSV